Our Story

SurePulse develop monitoring solutions for the unique needs of newborns. The company was born out of a collaboration between the School of Electrical and Electronic Engineering and the Department of Academic Child Health at the University of Nottingham, after researchers realised that vital sign technology being developed within the University could be applied to monitor newborn babies who need help at birth. Current approaches are insufficiently accurate, reliable or timely which can lead to deviations from International protocols for delivery room care.

Existing vital sign monitoring techniques and technologies are not suitable for newborn babies due to ergonomic and physiological factors and have been adapted from devices originally designed for use in adults or children. SurePulse put babies, parents, and clinical staff at the heart of their product design (Pickup, 2019).

SurePulse Medical Ltd was incorporated to tackle these problems and is a joint venture between the University of Nottingham and Simpatica Group Ltd. This collaboration combines the academic strength of the University with the commercial and manufacturing capabilities of one of the UK’s premier contract manufacturers.

The SurePulse Board of Directors and Management Team are hugely experienced in MedTech design, development, commercialisation, investor relations, and strategic alignment. The success of the first product to be developed and launched (CE approved 2019), the SurePulse VS wireless heart rate monitor for newborn babies, has been recognised with Medilink East Midlands Business Awards for Innovation and Start-Up.